Recombinant Anti-CD20 x Anti-CD22 Bispecific Antibody (Tandem scFv) is designed to be expressed as a scFv from an anti-CD20 antibody variable domains fused with a scFv from an anti-CD22 antibody variable domains. It contains a His-tag at the C/N terminus for affinity purification. The BsAb exits as monomer in reducing and non-reducing conditions. This BsAb is designed for the research of Lymphoma; Leukemia; Antoimmune disease; Immune dysfunction disease therapy.
Welcome! For price inquiries, we will get back to you as soon as possible.
INQUIRY